MedPath
NMPA Approval

Rivastigmine Hydrogen Tartrate Capsules

国药准字H20203011

October 16, 2024

Drug Information

重酒石酸卡巴拉汀胶囊

胶囊剂

按C14H22N2O2计 1.5mg

化学药品

October 16, 2024

Company Information

Applicant Company

北京市通州区张家湾镇齐善庄村东

Manufacturing Company

北京市通州区张家湾镇广源西街13号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重酒石酸卡巴拉汀胶囊 - NMPA 批准文号 | MedPath